首页> 外文期刊>Journal of cutaneous pathology >The significance of multiplex PCR/heteroduplex analysis-based TCR-γ gene rearrangement combined with laser-capture microdissection in the diagnosis of early mycosis fungoides
【24h】

The significance of multiplex PCR/heteroduplex analysis-based TCR-γ gene rearrangement combined with laser-capture microdissection in the diagnosis of early mycosis fungoides

机译:基于多重PCR /异源双链分析的TCR-γ基因重排结合激光捕获显微切割在早期真菌病真菌诊断中的意义

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The diagnosis of early mycosis fungoides (MF) is a big challenge to dermatologists and dermatopathologists because it lacks specific clinicopathologic features. Methods: Fifty-two paraffin-embedded skin samples from 50 patients, including 31 with suspected MF, 10 with typical MF and 9 with benign inflammatory dermatosis (BID), were obtained from our archives. DNA was extracted both by traditional phenol-chloroform method and by the laser-capture microdissection (LCM)-proteinase K approach. The T VG/T JG, V 2-5/V 8-12/JGT 1 and BIOMED-2-TCR-Iγ primers were used to assess TCR-Iγ monoclonal rearrangement as measured by polymerase chain reaction (PCR). Results: In the suspected MF group, clonal TCR-Iγ gene rearrangements were detected in 11/31 cases (35.5%) by phenol-chloroform DNA extraction and in 25/31 cases (80.7%) by LCM-proteinase K extraction (p 0.05). While T-cell clonality was detected in 8/10 cases (80%) by the phenol-chloroform method and 10/10 cases (100%) by LCM (p 0.05) in the typical MF group, no TCR-Iγ monoclonal rearrangement was detected in the BID group. Conclusions: The strategy of multiple PCR/heteroduplex analysis for TCR-Iγ gene rearrangement combined with LCM increases the detection rate of clonal TCR-Iγ gene rearrangement in early MF cases and could provide strong evidence to confirm the diagnosis of early MF.
机译:背景:早期真菌病真菌(MF)的诊断是皮肤科医生和皮肤病理学家的一大挑战,因为它缺乏特定的临床病理特征。方法:从我们的档案中获得了50例患者的52种石蜡包埋的皮肤样本,其中包括31例疑似MF,10例典型MF和9例良性炎症性皮肤病(BID)。通过传统的苯酚-氯仿方法和激光捕获显微切割(LCM)-蛋白酶K方法提取DNA。 T VG / T JG,V 2-5 / V 8-12 / JGT 1和BIOMED-2-TCR-Iγ引物用于评估通过聚合酶链反应(PCR)测量的TCR-Iγ单克隆重排。结果:在疑似MF组中,通过苯酚-氯仿DNA提取检测到11/31例(35.5%)的克隆TCR-Iγ基因重排,通过LCM蛋白酶K提取检测到25/31例(80.7%)(p < 0.05)。在典型的MF组中,通过苯酚-氯仿法检测到8/10例(80%)T细胞克隆性,通过LCM检测到10/10例(100%)(p> 0.05),但没有TCR-Iγ单克隆重排在BID组中被检测到。结论:TCR-Iγ基因重排结合LCM的多重PCR /异源双链分析策略提高了早期MF患者克隆TCR-Iγ基因重排的检测率,可以为早期MF的诊断提供强有力的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号